Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Celgene Corporation, Australasian Leukaemia and Lymphoma Group (ALLG)
Scientific Title
Single Arm, Multicentre Study of Carfilzomib in Combination With Thalidomide and Dexamethasone (CaTD) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)